The Valley Desk

NCT03517488 · Interventional trial

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Overall registry status Completed

Phase 1

Conditions Basal Cell Carcinoma, Breast Carcinoma, Castration-Resistant Prostate Carcinoma, Cervical Cancer, Cholangiocarcinoma, Colorectal Carcinoma, Endometrial Carcinoma, Fallopian Tube Carcinoma, Gastric or Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma, Malignant Adnexal Neoplasms, Melanoma, Mesothelioma, Nasopharyngeal Carcinoma, Neuroendocrine Carcinoma, Non-small Cell Lung Carcinoma, Non-squamous Cell Salivary Gland Carcinoma, Ovarian Carcinoma, Renal Cell Carcinoma, Small Cell Lung Carcinoma, Solid Tumors With Published Evidence of Anti-tumor Activity With Anti-PD1/PDL1 and/or Anti-CTLA4-directed Therapy, Squamous Cell Carcinoma of the Anus, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Penis, Thymic Carcinoma, Thymoma, Urothelial Carcinoma, Vulvar Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov